相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
X. Rao et al.
ONCOGENE (2011)
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27
Michela Frenquelli et al.
BLOOD (2010)
Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer
Gottfried E. Konecny et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
Xing-xiang Pu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction
J. -F. Mouillet et al.
PLACENTA (2010)
Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis
Reiki Nishimura et al.
BREAST CANCER (2010)
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy
Marco Colleoni et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases
Maria Angelica Cortez et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Measuring microRNAs: Comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods
Robert A. Ach et al.
BMC BIOTECHNOLOGY (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
MicroRNA-221/222 Negatively Regulates Estrogen Receptor α and Is Associated with Tamoxifen Resistance in Breast Cancer
Jian-Jun Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast
Gunter von Minckwitz et al.
BREAST CANCER RESEARCH (2008)
Roles of microRNAs and their targets in cancer
Giovanni Stefani
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1*
Silvia Galardi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Primary systemic chemotherapy of invasive lobular carcinoma of the breast
Artur Katz et al.
LANCET ONCOLOGY (2007)
被撤回的出版物: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial (Retracted Article. See vol 12, pg 116, 2011)
[Anonymous]
LANCET ONCOLOGY (2007)
The role of microRNA genes in papillary thyroid carcinoma
HL He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
J Takamizawa et al.
CANCER RESEARCH (2004)
Pathobiology of preoperative chemotherapy - Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-18
ER Fisher et al.
CANCER (2002)
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer
JY Pierga et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
